Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Retrospective Post Market Clinical Follow-up (PMCF) Study Evaluating the Safety and Clinical Performance of the SABER (OTW) PTA Dilatation Catheter, SABERX PTA Dilatation Catheter, and Powerflex Pro PTA Catheter Used in Infra-popliteal Vessels, During Percutaneous Transluminal Angioplasty (PTA) Procedures.

NCT05444660 is registered in ClinicalTrials.gov with Cordis US Corp. as lead sponsor.

NCT NCT05444660
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05444660 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Retrospective Post Market Clinical Follow-up (PMCF) Study Evaluating the Safety and Clinical Performance of the SABER (OTW) PTA Dilatation Catheter, SABERX PTA Dilatation Catheter, and Powerflex Pro PTA Catheter Used in Infra-popliteal Vessels, During Percutaneous Transluminal Angioplasty (PTA) Procedures.
Lead sponsor
Cordis US Corp.
Phase
Observational
Overall status
Completed
Start date
May 5, 2022
Completion date
November 2, 2022
Enrollment
102 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

peripheral artery disease